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This Dutch thesis is based on a number of studies, which have been published in
English-written profe ssional journals. To offer more detailed information and in behalf of the
foreign reader reprints of these publications have been added to this thesis (Appendices A upto
E) .
The principal question of the studies described within this thesis is what specific information
can be derived from images as shown on page 1. On this picture the distribution of dopamine
(DA) receptors in the living human brain has been visualized using a specific imaging
technique: positron-emission tomography (PET).
This brief introduction is followed by a more extensive one (Chapter I). Aspects of the
neurotransmitter system studied, the central dopaminergic (DA-ergic) system (I.1 and I.2), the
role of this system in several disorders (I.4), as well as diagnostic methods used upto now
(I.3) are reviewed. Partly due to its involvement in Parkinson's disease, the knowledge of the
central DA-ergic system has assumed enormous proportions during the last 25 years. Most of
it, however, is based on studies with experimental animals. For direct investigation of the
system is hindered by its localization within the skull and behind the blood-brain barrier. The
latter also hinders a directly verifying of the insights obtained from studies with animals,
although postmortem obtained material often appears to be useful. Also the diagnostic methods
used till now are indirect and often only indicate large defects, giving mostly no information
about regional aspects i.e. the localization of the defect within the brain.
Next the principles are described of a number of non-invasive imaging techniques, that can
make important contributions to brain research (I.5). Especially PET is very suitable by the
combination of its relatively large spatial resolution with the fact that, provided that a good
choice is made for the positron-emitting radiopharmaceutical, a tomogram can be obtained of
all kinds of processes in the living brain at the molecular level. The various appÍoaches in
research of the cerebral DA-ergic neurotransmission using PET are reviewed (I.6). It appears
that by far most studies are focused on visualizing specific elements of the DA-ergic neuronal
system viz. the DA receptors.
After a short review of the performed studies (Chapter II, with reference to the Appendices
already mentioned above) the innoduction is followed by description and discussion of the
most important results of the investigations (Chapter III). In all studies the rat was rhe
experimental animal of choice. Tritium (3H)-taUetled spiperone, a DA and seroronin (s-Fil)
antagonist, and 3H-NPA, a DA agonist, were used.
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First, using a number of pharmacological criteria, the suitability of NPA for the in vivo
radioactive labelling of DA receptors in the bnain, was investigated. This appeared possible and
optimal labelling conditions were established (III.1.2). Similar studies, using 3H-spiperone,
had already been published.
A method was developed for the rapid labelling of derivatives of the DA agonist ADTN with
the positron-emitter carbon-11. From animal experiments these compounds appeared,
however, to be not suitable for the in vivo labelling of DA receptors in brain 0II.1.3).
Neuronal localization and identification of striatal DA receptors, labelle d ín vívo with 3g-t IpA
or 3H-spiperone, were determined (III.2). Using various lesioning techniques, different parts
of striatal innervation were destroyed. Following tracer doses 3g-NpA or 3H-spiperone, these
lesions appeared to have very different effects on striatal radioactivity accumulation, with both
compounds. Removal of DA-ergic innervation led to higher striatal radioactivity levels in the
lesioned structure following 3g-NpR injection, while with 3H-spiperone no differences were
observed. Destroying striatal neurones (using kainic acid) led, in the lesioned striatum, to
lower radioactivity accumulation following 3g-Np,q. and higher following 3H-spiperone.
These apparently paradoxical observations in the lesioned striata could be explained for both
compounds by quantitative analysis of the dose-dependency of radioactivity accumulations
(III.2 and III.4). From changes in receptor densities all striatal DA receptors that could be
labelled in vivo with NPA, appeared to be localized postsynaptically. This was also found with
spiperone. Nearly all (80Eo) DA receptors labelled with NPA were present on striatal neurones,
the remaining on cortico-striatal projections. Of the DA receptors labelled with spiperone, also
the major part (567o) appeared sensitive for kainic acid and a minor part (I4Vo) disappeared
after decortication. Part of striatal spiperone binding remained undefined. It is remarkable that
the number of spiperone binding sites that disappeared was about twice that of NPA for both
kainic acid and cortical lesionine.
In addition to the quantitative analysis of localization of in vivo NPA and spiperone binding, it
has also been studied to what extent occupation of striatal DA receptors is coupled to
biochemical effects (III.3). From these studies it has appeared that in the striatum an increasing
occupation of DA receptors by NPA is not linearly correlated with (decreased) striatal DA
metabolite (HVA and DOPAC) and (increased) acetylcholine (AcCh) concentrations. Striatal


























ptors that could be




.t is remarkable that
rat of NPA for both
piperone binding, it




:al DA receptors by
From these investigations it is concluded that in the rat cerebral DA receptors can be detected tn
vivo with both radiolabelled NPA and spiperone. In both cases the postsynaptically localized
DA receptor of the D-2 type is tagged. From the studies with lesions for both ligands neither
qualitatively nor quantitatively correct information about the changes of receptor densities was
obtained in the experiments using tracer doses. This finding may hinder direct "on screen"
intèrpretation of PET images. To solve this problem the use of more intricated, computer-
analyzed mathematical models in combination with studies at various doses, will be necessary.
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